Spotlight on Antibodies is a podcast from ⁠Biointron⁠, where we bring you the latest antibody industry trends. This September we'll highlight recent approvals in biosimilar drugs, conjugate linker designs, and discovery platform advances.

References

1. https://bmcimmunol.biomedcentral.com/articles/10.1186/s12865-025-00693-9
2. https://pmc.ncbi.nlm.nih.gov/articles/PMC12185665/
3. https://www.prnewswire.com/news-releases/professor-sarfaraz-k-niazi-secures-first-ever-fda-acceptance-to-waive-clinical-efficacy-studies-for-monoclonal-antibody-biosimilars-302542781.html
4. https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202500262
5. https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c01500
6. https://www.sciencedirect.com/org/science/article/pii/S1520480424010044
7. https://www.nature.com/articles/s41598-025-13810-w
8. https://www.mdpi.com/1424-8247/18/8/1198
9. https://jbioleng.biomedcentral.com/articles/10.1186/s13036-025-00513-z
10. https://news.illinois.edu/high-volume-antibody-testing-platform-could-accelerate-disease-research-and-treatment-development/
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC11623700/
12. https://pubs.rsc.org/en/content/articlehtml/2025/lc/d5lc00340g